CCR5 expression on macrophages/microglia is associated with early remyelination in multiple sclerosis lesions

Abstract

Remyelination in multiple sclerosis (MS) occurs spontaneously and extensively. The underlying mechanisms, however, are only partly understood. Findings in experimental animal settings suggest that inflammation promotes remyelination and repair. Here, we characterized the chemokine receptor expression profiles of macrophages/microglia in early remyelinating and completely remyelinated lesions compared with active demyelinating and inactive demyelinated MS lesions obtained in the early disease course. Biopsy material consisting of 16 MS cases was available for this study. We found that macrophages/microglia within early remyelinating lesions expressed predominantly CCR5. Our findings implicate a possible role of CCR5⁺ cells in initiating remyelination.

Keywords

chemokine receptor macrophages microglia multiple sclerosis remyelination

Get full access to this article

View all access options for this article.

References

1 Patrikios P Stadelmann C Kutzelnigg A . Remyelination is extensive in a subset of multiple sclerosis patients. Brain 2006; 129: 3165 – 3172 .

2 Lucchinetti C Brück W Parisi J Scheithauer B Rodriguez M Lassmann H . Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000; 47: 707 – 717 .

3 Arnett HA Wang Y Matsushima GK Suzuki K Ting JP . Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J Neurosci 2003; 23: 9824 – 9832 .

4 Kotter MR Setzu A Sim FJ Van Rooijen N Franklin RJ . Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 2001; 35: 204 – 212 .

5 Kotter MR Zhao C Van Rooijen N Franklin RJ . Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 2005; 18: 166 – 175 .

6 Li WW Setzu A Zhao C Franklin RJ . Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 2005; 158: 58 – 66 .

7 Trebst C Sørensen TL Kivisäkk P . CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. Am J Pathol 2001; 159: 1701 – 1710 .

8 Mahad DJ Trebst C Kivisäkk P . Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and III multiple sclerosis lesions. J Neuropathol Exp Neurol 2004; 63: 262 – 273 .

9 Brück W Porada P Poser S . Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995; 38: 788 – 796 .

10.

10 Lucchinetti CF Brück W Rodriguez M Lassmann H . Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol 1996; 6: 259 – 274 .

11.

11 Brück W Kuhlmann T Stadelmann C . Remyelination in multiple sclerosis. J Neurol Sci 2003; 206: 181 – 185 .

12.

12 Kivisäkk P Mahad DJ Callahan MK . Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann Neurol 2004; 55: 627 – 638 .

13.

13 Sørensen TL Tani M Jensen J . Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 1999; 103: 807 – 815 .

14.

14 Boven LA Van Meurs M Van Zwam M . Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis. Brain 2006; 129: 517 – 526 .

15.

15 van Rossum D Hilbert S Strassenburg S Hanisch UK Bruck W . Myelin-phagocytosing macrophages in isolated sciatic and optic nerves reveal a unique reactive phenotype. Glia 2008; 56: 271 – 283 .

16.

16 Hanisch UK Kettenmann H . Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 2007; 10: 1387 – 1394 .

17.

17 Lai AY Todd KG . Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury. Glia 2008; 56: 259 – 270 .

18.

18 Jurevics H Largent C Hostettler J . Alterations in metabolism and gene expression in brain regions during cuprizone-induced demyelination and remyelination. J Neurochem 2002; 82: 126 – 136 .

19.

19 McMahon EJ Cook DN Suzuki K Matsushima GK . Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier. J Immunol 2001; 167: 2964 – 2971 .

20.

20 Bennetts BH Teutsch SM Buhler MM Heard RN Stewart GJ . The CCR5 deletion mutation fails to protect against multiple sclerosis. Hum Immunol 1997; 58: 52 – 59 .

21.

21 Silversides JA Heggarty SV McDonnell GV Hawkins SA Graham CA . Influence of CCR5 delta32 polymorphism on multiple sclerosis susceptibility and disease course. Mult Scler 2004; 10: 149 – 152 .

22.

22 Sellebjerg F Madsen HO Jensen CV Jensen J Garred P . CCR5 delta32, matrix metalloproteinase-9 and disease activity in multiple sclerosis. J Neuroimmunol 2000; 102: 98 – 106 .

23.

23 Kantarci OH Morales Y Ziemer PA . CCR5Delta32 polymorphism effects on CCR5 expression, patterns of immunopathology and disease course in multiple sclerosis. J Neuroimmunol 2005; 169: 137 – 143 .

24.

24 Gade-Andavolu R Comings DE MacMurray J . Association of CCR5 delta32 deletion with early death in multiple sclerosis. Genet Med 2004; 6: 126 – 131 .